(ICEL) (ICEL) Stock Price, News & Analysis

Company Overview

Cellular Dynamics International, Inc. develops and produces functioning human cells in industrial quantities. The Company's products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics. It is also in the process of developing human cells as cellular therapeutics. The market for in vitro drug discovery, toxicity testing and applied testing, including chemical safety, has employed models, such as primary cells, transformed (immortalized) cells and live animals that act as surrogates for functioning human cells. Its iCell and MyCell products consist of iCell Cardiomyocytes, iCell Neurons, iCell DopaNeurons, iCell Endothelial Cells, iCell Hepatocytes, MyCell and Media and reprogramming kit.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 264,387 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ICEL Stock Analysis - Frequently Asked Questions

How were (ICEL)'s earnings last quarter?

(ICEL) (NASDAQ:ICEL) posted its earnings results on Thursday, March, 5th. The company reported ($0.36) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.08. The business had revenue of $6.60 million for the quarter, compared to analyst estimates of $5 million.

What other stocks do shareholders of (ICEL) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (ICEL) investors own include Bank of America (BAC), Bristol Myers Squibb (BMY), Avid Bioservices (CDMO), Clovis Oncology (CLVS), Corcept Therapeutics (CORT), CRISPR Therapeutics (CRSP) and CTI BioPharma (CTIC).

Company Calendar

• Last Earnings: 3/05/2015
• Today: 7/14/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ICEL
• CIK: 1482080
• Web: www.cellulardynamics.com
• Phone: +1-608-3105100
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A